OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

ACTION Trial

CAR T-Cell Therapy

Her2-Positive Breast Cancer

FDA Approval

Ponatinib

Swog 1826

Multiple Myeloma

Siltocaptagine Autolucel

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

31 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

In today’s episode, we spoke with Nicholas Short, MD. Dr Short is an associate professor in the Department of Leukemia of the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston.

In our exclusive interview, Dr... more

13 Feb 2026 • 16 min

S16 Ep3: Third-Line Treatment Selection in mCRC Is Shaped By Recalibration of Patient Priorities and Molecular Retesting: With Christopher Lieu, MD

In today’s episode, Christopher Lieu, MD, reviewed current treatment strategies and factors informing sequencing decisions for patients with metastatic colorectal cancer (mCRC) in the third-line setting. Lieu is co-director of the Gastrointestinal Me... more

11 Feb 2026 • 12 min

S16 Ep2: “D” is for Diagnosis: Decoding a Difficult Thoracic Malignancy—Piecing Together a Rare Diagnosis, Preparing for Tomorrow’s Treatments

In this podcast, experts Aakash Desai, MBBS, MPH; Ibiayi Dagogo-Jack, MD; and Patrick Forde, MBBCh, PhD, discuss how to decode the diagnosis of malignant pleural mesothelioma and review data to optimize frontline and subsequent treatment of this rare... more

11 Feb 2026 • 29 min

S16 Ep1: Targeted Therapies Take Center Stage for Estrogen Receptor–Positive Breast Cancer: With Aditya Bardia, MD, MPH, FASCO

In today’s episode, our discussion features Aditya Bardia, MD, MPH, FASCO. Dr Bardia is a professor in the Department of Medicine in the Division of Hematology/Oncology, the director of Translational Research Integration, and a member of Signal Trans... more

10 Feb 2026 • 9 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Lung Cancer ConsideredIASLC

Recent Guests

Nicholas Short

Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center

Episode: S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

Christopher Lieu, MD

Co-director of the Gastrointestinal Medical Oncology Program and professor of medicine in the Department of Medical Oncology at the University of Colorado Cancer Center.

University of Colorado Cancer Center

Episode: S16 Ep3: Third-Line Treatment Selection in mCRC Is Shaped By Recalibration of Patient Priorities and Molecular Retesting: With Christopher Lieu, MD

Komal Jhaveri, MD, FACP

Oncology expert and speaker at the OncLive® State of the Science Summits.

Episode: S15 Ep47: ASCENT-07 Trial Propels Further Questions About the Role of Earlier-Line ADCs in HR+ Metastatic Breast Cancer: With Komal Jhaveri, MD, FACP

Andrew Lipsky, MD

Assistant professor of medicine at Columbia University Medical Center

Columbia University Medical Center

Episode: S15 Ep46: Expanded BTK Inhibitor Research Directs the Evolution of Pirtobrutinib Use in CLL: With Andrew Lipsky, MD

Sikander Ailawadhi

Medical Doctor specializing in oncology

Oncology and Hematology

Episode: S15 Ep44: Subcutaneous Isatuximab via On-Body Injector Has Noninferior Efficacy vs IV Delivery in Myeloma: With Sikander Ailawadhi, MD; and Beth Faiman, CNP, PhD

Tycel Phillips, MD

Oncologist discussing Epcoritamab trial results

Episode: S15 Ep42: Long-Term Epcoritamab Data Show Durable Responses and Confirmed Safety in LBCL: With Tycel Phillips, MD

Rebecca Porter

Medical Oncologist and Director of Immunotherapy Research

Dana-Farber Cancer Institute

Episode: S15 Ep37: Immuno-Oncology and Novel Cell Therapies Set Transformation in Motion for Gynecologic Oncology: With Ursula A. Matulonis, MD; and Rebecca Porter, MD, PhD

Rahul Banerjee

MD, FACP specialized in oncology

Episode: S15 Ep28: Emerging CELMoDs Set New Standards for Efficacy and Tolerability in Myeloma: With Rahul Banerjee, MD, FACP

Lorenzo Falchi, MD

Clinical and regulatory expert discussing FDA approval

Episode: S15 Ep26: FDA Approval Insights: Epcoritamab Plus Rituximab/Lenalidomide for Relapsed/Refractory Follicular Lymphoma: With Lorenzo Falchi, MD

Hosts

Gregory J. Tiesi

Chief of Surgical Oncology discussing innovative regional cancer therapies and patient management strategies.

Unknown

Host of interviews with various oncologists and discussions around oncology practices and updates.

Reviews

4.5 out of 5 stars from 31 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States8 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The discussions are informative for professionals in the medical field, making it a valuable resource for anyone working in oncology.

Listeners appreciate the high-quality content focused on the latest advancements in oncology.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts

#161

Ireland/Health & Fitness

Talking Points

Recent interactions between the hosts and their guests.

S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

Q: What are your thoughts on the evolving treatment strategies for Ph+ ALL?

The paradigm has shifted towards chemotherapy-free regimens combined with TKIs, which seem to yield good outcomes and are often preferred by patients.

S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

Q: What is your current approach in utilizing Ponatinib?

Ponatinib is usually the go-to frontline TKI unless a patient has specific contraindications.

S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

Q: How does the presence of T315I mutations affect treatment decisions?

These mutations are significant as they can drive resistance in patients treated with first or second generation TKIs, but the impact on initial therapy selection is limited since they may not be present at diagnosis.

S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

Q: What are some of the factors that ultimately drive TKI selection for an individual patient?

Factors include toxicity profiles and contraindications for each medication, such as cardiovascular issues or other associated risks.

S16 Ep1: Targeted Therapies Take Center Stage for Estrogen Receptor–Positive Breast Cancer: With Aditya Bardia, MD, MPH, FASCO

Q: Could you recap the key efficacy findings that I read out from Lidera at SBCS?

Dr. Bardia explained that the Lidera study showed gerodesterone is superior to standard endocrine therapies in promoting invasive disease-free survival for patients with localized breast cancer.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Content focuses on discussions with leading oncologists covering a broad spectrum of topics in oncology, including systemic therapies, surgical techniques, and innovations in radiation therapy. Episodes reflect on the latest advancements and therapeutic approaches across various cancer types, such as lung, breast, gastrointestinal, and hematologic malignancies, as well as gynecologic and genitourinary cancers. The informative interviews not only present the current state of cancer treatment but also emphasize the importance of research and clinical trials in shaping future strategies for cancer care.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. Oncology Today with Dr Neil Love
3. Research To Practice | Oncology Videos
4. ASCO Daily News
5. Lung Cancer Considered

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Nicholas Short
2. Christopher Lieu, MD
3. Komal Jhaveri, MD, FACP
4. Andrew Lipsky, MD
5. Sikander Ailawadhi
6. Tycel Phillips, MD
7. Rebecca Porter
8. Rahul Banerjee

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days